• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Biotech USD

+ Add to Watchlist

UBFC:TH

444.8340 EUR 0.00000.00%

As of 05:03:57 ET on 12/16/2014.

Snapshot for UBS Lux Equity Fund - Biotech USD (UBFC)

Open: - High - Low: - Primary Exchange: Tradegate
Volume: 100 52-Week Range: 275.5400 - 469.0720 Beta vs NSESWRLD: -

ETF Chart for UBFC

No chart data available.
  • UBFC:TH 444.8340
  • 1D
  • 1M
  • 1Y
444.8340
Interactive UBFC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBFC

UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.

Inception Date: 1996-10-15 Telephone: 352-44-10-10-1 Tel
Managers: ANGUS W H MUIRHEAD / NATHALIE LOTSCHER PETRUS
Web Site: www.ubs.com

Fundamentals for UBFC

NAV -
Assets (M) (on 2014-12-18) 1,490.9120
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for UBFC

No dividends reported

Performance for UBFC

1-Month +4.31% 1-Year +61.10%
3-Month +10.56% 3-Year -
Year To Date +55.72% 5-Year -
Expense Ratio 2.08

Top Fund Holdings for UBFC

Filing Date: 09/30/2014
Name Position Value % of Total
Gilead Sciences Inc 1,102,400 117,350,480 9.900%
Biogen Idec Inc 347,500 114,956,475 9.698%
Amgen Inc 767,214 107,762,878 9.091%
Celgene Corp 981,820 93,056,900 7.851%
Regeneron Pharmaceuticals Inc 162,200 58,476,344 4.933%
Vertex Pharmaceuticals Inc 518,100 58,187,811 4.909%
BioMarin Pharmaceutical Inc 801,300 57,821,808 4.878%
Alexion Pharmaceuticals Inc 344,500 57,124,990 4.819%
Medivation Inc 538,500 53,241,495 4.492%
Alkermes PLC 923,293 39,581,571 3.339%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil